CA2439702A1 - Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof - Google Patents

Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof Download PDF

Info

Publication number
CA2439702A1
CA2439702A1 CA002439702A CA2439702A CA2439702A1 CA 2439702 A1 CA2439702 A1 CA 2439702A1 CA 002439702 A CA002439702 A CA 002439702A CA 2439702 A CA2439702 A CA 2439702A CA 2439702 A1 CA2439702 A1 CA 2439702A1
Authority
CA
Canada
Prior art keywords
nucleic acid
polypeptide
abcc11
seq
nucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002439702A
Other languages
English (en)
French (fr)
Inventor
Marie-Francoise Rosier-Montus
Catherine Prades
Isabelle Arnould-Reguigne
Michael Dean
Rando Allikmets
Patrice Denefle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Government of the United States of America
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2439702A1 publication Critical patent/CA2439702A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
CA002439702A 2001-03-05 2002-03-05 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof Abandoned CA2439702A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27275701P 2001-03-05 2001-03-05
US60/272,757 2001-03-05
PCT/EP2002/003241 WO2002072632A2 (en) 2001-03-05 2002-03-05 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof.

Publications (1)

Publication Number Publication Date
CA2439702A1 true CA2439702A1 (en) 2002-09-19

Family

ID=23041140

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002439702A Abandoned CA2439702A1 (en) 2001-03-05 2002-03-05 Nucleic acids of the human abcc11 gene, vectors containing such nucleic acids and uses thereof

Country Status (5)

Country Link
US (2) US6893841B2 (https=)
EP (1) EP1385884A2 (https=)
JP (1) JP2004531241A (https=)
CA (1) CA2439702A1 (https=)
WO (1) WO2002072632A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2439693A1 (en) * 2001-03-05 2002-10-31 Aventis Pharma S.A. Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
WO2002072825A2 (en) * 2001-03-09 2002-09-19 Bayer Aktiengesellschaft Human mrp5-like protein
WO2003076571A2 (en) * 2002-03-04 2003-09-18 Avalon Pharmaceuticals Cancer-linked gene as target for chemotherapy
US20080025981A1 (en) * 2002-03-04 2008-01-31 Young Paul E Cancer-linked genes as targets for chemotherapy
US20040049399A1 (en) * 2002-09-10 2004-03-11 Elisabeth Familian Method and system for online donation and sending customized card
JP4967135B2 (ja) * 2005-06-17 2012-07-04 国立大学法人 長崎大学 耳垢型又は腋下臭症の評価方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7268222B1 (en) * 1999-11-02 2007-09-11 Lexicon Pharmaceuticals, Inc. Polynucleotides encoding human transporter proteins
US20030032021A1 (en) * 2000-08-21 2003-02-13 Curtis Rory A. J. 44589, a novel human ABC transporter family member and uses thereof
AU2002215345A1 (en) * 2000-10-13 2002-04-22 Eos Biotechnology, Inc. Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
CA2439693A1 (en) * 2001-03-05 2002-10-31 Aventis Pharma S.A. Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof

Also Published As

Publication number Publication date
WO2002072632A3 (en) 2003-11-27
US20050158784A1 (en) 2005-07-21
JP2004531241A (ja) 2004-10-14
EP1385884A2 (en) 2004-02-04
US6893841B2 (en) 2005-05-17
US20030059793A1 (en) 2003-03-27
WO2002072632A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
EP1281755A2 (en) Variants of the human cyp2d6 gene
US20040132021A1 (en) Osteolevin gene polymorphisms
US6893841B2 (en) Nucleic acids of the human ABCC11 gene, vectors containing such nucleic acids and uses thereof
EP1773860A1 (en) Methods for identifying risk of type ii diabetes and treatments thereof
EP1213352A1 (en) Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
EP1096012A1 (en) Nucleics acids of the human ABC1 gene and their therapeutic and diagnostic application
US20030087246A1 (en) Nucleic acids of the human ABCA12 gene, vectors containing such nucleic acids and uses thereof
WO2003064471A2 (en) Gene for peripheral arterial occlusive disease
AU2003201728A1 (en) Gene for peripheral arterial occlusive disease
US20060141462A1 (en) Human type II diabetes gene-slit-3 located on chromosome 5q35
US20030077605A1 (en) Nucleic acids of the human ABCC12 gene, vectors containing such nucleic acids, and uses thereof
US20060063166A1 (en) Nucleic acids of the human ABCC12 gene, vectors containing such nucleic acids and uses thereof
CA2439693A1 (en) Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
US6998474B1 (en) Polypeptides of the “basic helix-loop-helix” bHLH family, corresponding nucleic acid sequences
KR20020012279A (ko) 인간 유전자 에이비씨1에 상응하는 핵산 및 단백질
US6063576A (en) Actin mutations in dilated cardiomyopathy, a heritable form of heart failure
CA2501523A1 (en) Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5
WO1999045112A2 (en) Chromosome 11-linked coronary heart disease susceptibility gene chd1

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued